NCT05214482 2026-03-03A Study of AK112 in Advanced Malignant TumorsAkesoPhase 1/2 Completed154 enrolled
NCT05223231 2026-02-02Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant TumorsNanjing Leads Biolabs Co.,LtdPhase 1/2 Completed26 enrolled